C. Wickenhauser et al., Polycythemia vera megakaryocytes store and release lysozyme to a higher extent than megakaryocytes in secondary polycythemia (polyglobuly), LEUK RES, 23(3), 1999, pp. 299-306
Lysozyme, a myelomonocytic marker not only exerts bacteriolytic, but also i
mmunomodulatoric properties and was found to bind to the glycosaminoglycan
serglycin, an important constituent of the extracellular matrix (ECM). Path
ological serum lysozyme levels were described in chronic myeloproliferative
disorders (CMPDs) and other hematological conditions. In this context it i
s remarkable that in polycythemia rubra vera (PV), characterized by a proli
feration particularly of the megakaryo- and erythropoiesis, serum lysozyme
levels behave independently of the numbers of myelomonocytic cells in perip
heral blood. To elucidate whether megakaryopoiesis might be the source of t
he increased serum lysozyme, we performed an experimental study on isolated
and enriched megakaryocytes derived from bone marrow of patients with PV.
Findings were compared to a group of patients with reactive (smoker's) poly
globuly (PG). In confirmation of previous results, quantification of serum
lysozyme levels showed a slight elevation in the cohort of PV patients whic
h was not correlated with the leukocyte count. Applying an immunohistochemi
cal assay we were able to demonstrate intracytoplasmic lysozyme storage in
megakaryocytes. Moreover, performing the reverse hemolytic plaque assay (RH
PA), a technique which enables detection of secreted proteins at the single
cell level, we found that 54% of the PV, but only 3% of the PG megakaryocy
tes spontaneously secreted lysozyme. After rhIL-3 treatment the secretion o
f lysozyme remained unchanged in PV but increased to 14% in PG. These findi
ngs suggest that the extent of megakaryocytic lysozyme secretion might disc
riminate PV from reactive conditions. Although a direct involvement of lyso
zyme in the regulation of aberrant megakaryopoiesis in PV is not likely, th
e results of the present study point to the possibility that lysozyme could
be involved in the interactions of PV megakaryocytes with ECM. Moreover, t
he response to rhIL-3 significantly discriminates PV megakaryocytes from me
gakaryocytes of the PG group. (C) 1999 Elsevier Science Ltd. All rights res
erved.